NO164295C - Analogifremgangsmaate til fremstilling av terapeutisk aktive fluorerte benzyltriazolforbindelser. - Google Patents

Analogifremgangsmaate til fremstilling av terapeutisk aktive fluorerte benzyltriazolforbindelser.

Info

Publication number: NO164295C
Authority: NO; Norway
Prior art keywords: fluored; benzyltriazol; compounds; preparation; therapeutic active
Prior art date: 1985-04-18

Application number

NO861486A

Other languages

English (en)

Norwegian (no)

Other versions

NO164295B (no

NO861486L (no

Inventor

Rene Meier

Original Assignee

Ciba Geigy Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1985-04-18

Filing date

1986-04-16

Publication date

1990-09-19

1986-04-16 Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag

1986-10-20 Publication of NO861486L publication Critical patent/NO861486L/no

1990-06-11 Publication of NO164295B publication Critical patent/NO164295B/no

1990-09-19 Publication of NO164295C publication Critical patent/NO164295C/no

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C247/00—Compounds containing azido groups
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C33/00—Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
- C07C33/40—Halogenated unsaturated alcohols
- C07C33/46—Halogenated unsaturated alcohols containing only six-membered aromatic rings as cyclic parts
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pain & Pain Management (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Biomedical Technology (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

NO861486A 1985-04-18 1986-04-16 Analogifremgangsmaate til fremstilling av terapeutisk aktive fluorerte benzyltriazolforbindelser. NO164295C (no)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
CH166385		1985-04-18

Publications (3)

Publication Number	Publication Date
NO861486L NO861486L (no)	1986-10-20
NO164295B NO164295B (no)	1990-06-11
NO164295C true NO164295C (no)	1990-09-19

Family

ID=4215715

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO861486A NO164295C (no)	1985-04-18	1986-04-16	Analogifremgangsmaate til fremstilling av terapeutisk aktive fluorerte benzyltriazolforbindelser.

Country Status (22)

Country	Link
EP (1)	EP0199262B1 (fi)
JP (1)	JPS61243068A (fi)
KR (1)	KR900008810B1 (fi)
AU (1)	AU599024B2 (fi)
CA (1)	CA1272201A (fi)
CY (1)	CY1751A (fi)
DD (1)	DD245874A5 (fi)
DE (1)	DE3677626D1 (fi)
DK (1)	DK169720B1 (fi)
ES (2)	ES8800176A1 (fi)
FI (1)	FI93544C (fi)
GR (1)	GR861004B (fi)
HK (1)	HK1494A (fi)
HU (1)	HU203327B (fi)
IE (1)	IE58472B1 (fi)
IL (1)	IL78510A (fi)
MX (1)	MX9203628A (fi)
NO (1)	NO164295C (fi)
NZ (1)	NZ215871A (fi)
PH (1)	PH22568A (fi)
PT (1)	PT82400B (fi)
ZA (1)	ZA862873B (fi)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0151528B1 (en) *	1984-02-02	1990-07-04	Merck & Co. Inc.	5-(amino or substituted amino)-1,2,3-triazoles
AU2633897A (en) *	1996-04-19	1997-11-12	Novo Nordisk A/S	Solid phase and combinatorial synthesis of substituted 1,2,3-triazoles and of arrays of substituted 1,2,3-triazoles
US6156907A (en) *	1996-07-11	2000-12-05	Novartis Ag	Process for preparing 1-substituted 4-cyano-1,2,3-triazoles
TW526195B (en)	1997-06-10	2003-04-01	Novartis Ag	Crystal modifications of 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide and their use
TW513301B (en) *	1999-03-01	2002-12-11	Novartis Ag	Pharmaceutical composition for treatment of neuropathic pain and affective and attention disorders
WO2004106329A2 (en) *	2003-06-03	2004-12-09	Dr. Reddy's Laboratories Ltd.	Novel antiinfective compounds and their pharmaceutical compositions
IT1393368B1 (it) *	2009-03-23	2012-04-20	Dipharma Francis Srl	Metodo per la preparazione di rufinamide
IT1395736B1 (it)	2009-08-04	2012-10-19	Dipharma Francis Srl	Forme cristalline di rufinamide
ES2498267T3 (es) *	2010-04-30	2014-09-24	Laboratorios Lesvi, S.L.	Procedimiento mejorado para la preparación de un intermedio de rufinamida
ITMI20110718A1 (it)	2011-04-29	2012-10-30	Dipharma Francis Srl	Procedimento per la purificazione di rufinamide
WO2014120994A1 (en) *	2013-01-31	2014-08-07	The Johns Hopkins University	Rufinamide and derivatives and their use in modulating the gating process of human voltage-gated sodium channels
US9771335B2 (en) *	2015-07-31	2017-09-26	The Johns Hopkins University	Derivatives of rufinamide and their use in inhibtion of the activation of human voltage-gated sodium channels
EP3386491B1 (en)	2015-12-11	2021-12-08	Aarhus Universitet	Rufinamide for use in the treatment of myotonia
WO2021099481A1 (en)	2019-11-20	2021-05-27	Medichem, S.A.	Solid composition containing rufinamide

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1511195A (en) *	1976-10-18	1978-05-17	Ici America Inc	Triazole derivatives
FI834666A (fi) *	1982-12-23	1984-06-24	Ciba Geigy Ag	Foerfarande foer framstaellning av nya aralkyltriazolfoereningar.

1986
- 1986-04-14 FI FI861573A patent/FI93544C/fi not_active IP Right Cessation
- 1986-04-14 PH PH33651A patent/PH22568A/en unknown
- 1986-04-15 EP EP86105188A patent/EP0199262B1/de not_active Expired - Lifetime
- 1986-04-15 IL IL78510A patent/IL78510A/xx not_active IP Right Cessation
- 1986-04-15 DE DE8686105188T patent/DE3677626D1/de not_active Expired - Lifetime
- 1986-04-16 GR GR861004A patent/GR861004B/el unknown
- 1986-04-16 ES ES554024A patent/ES8800176A1/es not_active Expired
- 1986-04-16 CA CA000506774A patent/CA1272201A/en not_active Expired - Lifetime
- 1986-04-16 PT PT82400A patent/PT82400B/pt unknown
- 1986-04-16 NO NO861486A patent/NO164295C/no unknown
- 1986-04-16 DD DD86289243A patent/DD245874A5/de not_active IP Right Cessation
- 1986-04-17 AU AU56319/86A patent/AU599024B2/en not_active Expired
- 1986-04-17 ZA ZA862873A patent/ZA862873B/xx unknown
- 1986-04-17 IE IE101586A patent/IE58472B1/en not_active IP Right Cessation
- 1986-04-17 KR KR1019860002954A patent/KR900008810B1/ko not_active IP Right Cessation
- 1986-04-17 DK DK175686A patent/DK169720B1/da not_active IP Right Cessation
- 1986-04-17 HU HU861615A patent/HU203327B/hu unknown
- 1986-04-17 NZ NZ215871A patent/NZ215871A/xx unknown
- 1986-04-18 JP JP61088384A patent/JPS61243068A/ja active Granted
1987
- 1987-07-31 ES ES557641A patent/ES8802501A1/es not_active Expired
1992
- 1992-06-26 MX MX9203628A patent/MX9203628A/es unknown
1994
- 1994-01-06 HK HK14/94A patent/HK1494A/xx not_active IP Right Cessation
- 1994-06-03 CY CY175194A patent/CY1751A/xx unknown

Also Published As

Publication number	Publication date
PH22568A (en)	1988-10-17
ES557641A0 (es)	1988-07-01
MX9203628A (es)	1992-09-01
AU599024B2 (en)	1990-07-12
IL78510A0 (en)	1986-08-31
CY1751A (en)	1994-06-03
JPH0564949B2 (fi)	1993-09-16
JPS61243068A (ja)	1986-10-29
IL78510A (en)	1992-05-25
ZA862873B (en)	1986-12-30
FI861573A (fi)	1986-10-19
PT82400A (en)	1986-05-01
EP0199262A2 (de)	1986-10-29
EP0199262B1 (de)	1991-02-27
ES8800176A1 (es)	1987-10-16
AU5631986A (en)	1986-10-23
EP0199262A3 (en)	1987-08-26
NO164295B (no)	1990-06-11
KR860008152A (ko)	1986-11-12
GR861004B (en)	1986-08-12
KR900008810B1 (ko)	1990-11-30
DK175686A (da)	1986-10-19
CA1272201A (en)	1990-07-31
DE3677626D1 (de)	1991-04-04
DK169720B1 (da)	1995-01-23
HK1494A (en)	1994-01-14
PT82400B (pt)	1988-08-17
NZ215871A (en)	1989-01-27
FI93544C (fi)	1995-04-25
ES8802501A1 (es)	1988-07-01
ES554024A0 (es)	1987-10-16
NO861486L (no)	1986-10-20
HU203327B (en)	1991-07-29
FI93544B (fi)	1995-01-13
DD245874A5 (de)	1987-05-20
DK175686D0 (da)	1986-04-17
FI861573A0 (fi)	1986-04-14
IE58472B1 (en)	1993-09-22
IE861015L (en)	1986-10-18
HUT40792A (en)	1987-02-27

Similar Documents

Publication	Publication Date	Title
NO164025C (no)	1990-08-22	Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-imidazolylmetyl-tetrahydrokarbazolon-derivater.
NO871267L (no)	1987-09-28	Fremgangsmaate for fremstilling av terapeutisk aktive tiazepinforbindelser.
NO163857C (no)	1990-08-01	Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolidindionforbindelser.
NO864126D0 (no)	1986-10-16	Fremgangsmaate for fremstilling av terapeutisk aktive pyridon-derivater.
NO166865C (no)	1991-09-11	Analogifremgangsmaate til fremstilling av terapeutisk aktive o-glykosidforbindelser.
NO872946D0 (no)	1987-07-15	Analogifremgangsmaate for fremstilling av terapeutisk aktive benzensulfonamidoindanylforbindelser.
NO162189C (no)	1989-11-29	Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazopyridiner.
NO165397C (no)	1991-02-06	Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolforbindelser.
NO161497C (no)	1989-08-23	Analogifremgangsmaate for fremstilling av terapeutisk aktive 9a-aza-9a-homoerytromycin-derivater.
NO874153D0 (no)	1987-10-02	Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazo-benzoksazinon-derivater.
NO864674D0 (no)	1986-11-21	Fremgangsmaate for fremstilling av terapeutisk aktive cefemforbindelser.
NO862373D0 (no)	1986-06-13	Fremgangsmaate for fremstilling av terapeutisk aktive tienopyridoner.
NO883485D0 (no)	1988-08-05	Fremgangsmaate for fremstilling av terapeutisk aktive piperidinyl-isokinolinforbindelser.
NO164541C (no)	1990-10-17	Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater.
NO164295C (no)	1990-09-19	Analogifremgangsmaate til fremstilling av terapeutisk aktive fluorerte benzyltriazolforbindelser.
NO890155L (no)	1989-07-17	Fremgangsmaate for fremstilling av terapeutisk aktive indolpiperidin-forbindelser.
NO880667L (no)	1988-08-18	Fremgangsmaate for fremstilling av terapeutisk aktive arylpiperazinyl-alkylen-fenyl-heterocykliske forbindelser.
NO862372D0 (no)	1986-06-13	Fremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater.
NO861584L (no)	1986-10-24	Fremgangsmaate til fremstilling av terapeutisk aktive cyklopentyletere.
NO164899C (no)	1990-11-28	Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazolylindolforbindelser.
NO873680D0 (no)	1987-09-02	Analogifremgangsmaate for fremstilling av terapeutisk aktive sulfonamido-etyl-forbindelser.
NO164172C (no)	1990-09-05	Analogifremgangsmaate for fremstilling av terapeutisk aktive tricykliske tienokondenserte forbindelser.
NO163570C (no)	1990-06-20	Analogifremgangsmaate til fremstilling av terapeutisk aktive acylaminomitosaner.
NO162188C (no)	1989-11-29	Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazokinoliner.
NO864101D0 (no)	1986-10-14	Fremgangsmaate for fremstilling av terapeutisk aktive dikloranilinderivater.